327 related articles for article (PubMed ID: 22706327)
21. Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial.
D'Souza DC; Cortes-Briones J; Creatura G; Bluez G; Thurnauer H; Deaso E; Bielen K; Surti T; Radhakrishnan R; Gupta A; Gupta S; Cahill J; Sherif MA; Makriyannis A; Morgan PT; Ranganathan M; Skosnik PD
Lancet Psychiatry; 2019 Jan; 6(1):35-45. PubMed ID: 30528676
[TBL] [Abstract][Full Text] [Related]
22. Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial.
McRae-Clark AL; Baker NL; Gray KM; Killeen TK; Wagner AM; Brady KT; DeVane CL; Norton J
Drug Alcohol Depend; 2015 Nov; 156():29-37. PubMed ID: 26386827
[TBL] [Abstract][Full Text] [Related]
23. N-acetylcysteine versus placebo for treating nail biting, a double blind randomized placebo controlled clinical trial.
Ghanizadeh A; Derakhshan N; Berk M
Antiinflamm Antiallergy Agents Med Chem; 2013; 12(3):223-8. PubMed ID: 23651231
[TBL] [Abstract][Full Text] [Related]
24. A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol.
Maier A; Dharan A; Oliver G; Berk M; Redston S; Back SE; Kalivas P; Ng C; Kanaan RA
BMC Psychiatry; 2020 Aug; 20(1):397. PubMed ID: 32762663
[TBL] [Abstract][Full Text] [Related]
25. Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial.
Allsop DJ; Copeland J; Lintzeris N; Dunlop AJ; Montebello M; Sadler C; Rivas GR; Holland RM; Muhleisen P; Norberg MM; Booth J; McGregor IS
JAMA Psychiatry; 2014 Mar; 71(3):281-91. PubMed ID: 24430917
[TBL] [Abstract][Full Text] [Related]
26. A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder.
Wink LK; Adams R; Wang Z; Klaunig JE; Plawecki MH; Posey DJ; McDougle CJ; Erickson CA
Mol Autism; 2016; 7():26. PubMed ID: 27103982
[TBL] [Abstract][Full Text] [Related]
27. A double-blind placebo-controlled trial of N-acetylcysteine in the treatment of cocaine dependence.
LaRowe SD; Kalivas PW; Nicholas JS; Randall PK; Mardikian PN; Malcolm RJ
Am J Addict; 2013; 22(5):443-52. PubMed ID: 23952889
[TBL] [Abstract][Full Text] [Related]
28. N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled Study.
Sarris J; Oliver G; Camfield DA; Dean OM; Dowling N; Smith DJ; Murphy J; Menon R; Berk M; Blair-West S; Ng CH
CNS Drugs; 2015 Sep; 29(9):801-9. PubMed ID: 26374743
[TBL] [Abstract][Full Text] [Related]
29. Predictors of Topiramate Tolerability in Heavy Cannabis-Using Adolescents and Young Adults: A Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial.
Gray JC; Treloar Padovano H; Wemm SE; Miranda R
J Clin Psychopharmacol; 2018 Apr; 38(2):134-137. PubMed ID: 29424802
[TBL] [Abstract][Full Text] [Related]
30. A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults.
Mason BJ; Crean R; Goodell V; Light JM; Quello S; Shadan F; Buffkins K; Kyle M; Adusumalli M; Begovic A; Rao S
Neuropsychopharmacology; 2012 Jun; 37(7):1689-98. PubMed ID: 22373942
[TBL] [Abstract][Full Text] [Related]
31. Cognitive performance in a placebo-controlled pharmacotherapy trial for youth with marijuana dependence.
Roten A; Baker NL; Gray KM
Addict Behav; 2015 Jun; 45():119-23. PubMed ID: 25661990
[TBL] [Abstract][Full Text] [Related]
32. N-acetylcysteine does not alter neurometabolite levels in non-treatment seeking adolescents who use alcohol heavily: A preliminary randomized clinical trial.
Kirkland AE; Browning BD; Green R; Liu H; Maralit AM; Ferguson PL; Meyerhoff DJ; Prisciandaro JJ; Miranda R; Brady KT; Tomko RL; Gray KM; Squeglia LM
Neuropsychopharmacology; 2023 Jul; 48(8):1184-1193. PubMed ID: 36878996
[TBL] [Abstract][Full Text] [Related]
33. The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial.
Berk M; Dean OM; Cotton SM; Jeavons S; Tanious M; Kohlmann K; Hewitt K; Moss K; Allwang C; Schapkaitz I; Robbins J; Cobb H; Ng F; Dodd S; Bush AI; Malhi GS
J Clin Psychiatry; 2014 Jun; 75(6):628-36. PubMed ID: 25004186
[TBL] [Abstract][Full Text] [Related]
34. Topiramate and motivational enhancement therapy for cannabis use among youth: a randomized placebo-controlled pilot study.
Miranda R; Treloar H; Blanchard A; Justus A; Monti PM; Chun T; Swift R; Tidey JW; Gwaltney CJ
Addict Biol; 2017 May; 22(3):779-790. PubMed ID: 26752416
[TBL] [Abstract][Full Text] [Related]
35. N acetylcysteine in the treatment of alcohol use disorder: a randomized, double-blind, placebo-controlled trial.
Morley KC; Peruch S; Adams C; Towers E; Tremonti C; Watt J; Jamshidi N; Haber PS
Alcohol Alcohol; 2023 Sep; 58(5):553-560. PubMed ID: 37465907
[TBL] [Abstract][Full Text] [Related]
36. N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial.
Bloch MH; Panza KE; Yaffa A; Alvarenga PG; Jakubovski E; Mulqueen JM; Landeros-Weisenberger A; Leckman JF
J Child Adolesc Psychopharmacol; 2016 May; 26(4):327-34. PubMed ID: 27027204
[TBL] [Abstract][Full Text] [Related]
37. N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study.
Grant JE; Odlaug BL; Kim SW
Arch Gen Psychiatry; 2009 Jul; 66(7):756-63. PubMed ID: 19581567
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of N-acetylcysteine in the treatment of nicotine dependence: a double-blind placebo-controlled pilot study.
Schmaal L; Berk L; Hulstijn KP; Cousijn J; Wiers RW; van den Brink W
Eur Addict Res; 2011; 17(4):211-6. PubMed ID: 21606648
[TBL] [Abstract][Full Text] [Related]
39. N-Acetylcysteine for Pediatric Obsessive-Compulsive Disorder: A Small Pilot Study.
Li F; Welling MC; Johnson JA; Coughlin C; Mulqueen J; Jakubovski E; Coury S; Landeros-Weisenberger A; Bloch MH
J Child Adolesc Psychopharmacol; 2020 Feb; 30(1):32-37. PubMed ID: 31800306
[No Abstract] [Full Text] [Related]
40. A double-blind, randomized, controlled trial on N-acetylcysteine for the prevention of acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation.
Ataei S; Hadjibabaie M; Moslehi A; Taghizadeh-Ghehi M; Ashouri A; Amini E; Gholami K; Hayatshahi A; Vaezi M; Ghavamzadeh A
Hematol Oncol; 2015 Jun; 33(2):67-74. PubMed ID: 24711000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
